Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 116.30% is 814% above its 5-year average of -16.28%, around the middle of its 5-year range (-164.00%–384.04%).
11.93% above its 12-month average of 103.90%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 21.97%.
NET PROFIT MARGIN
116.30%
NET PROFIT MARGIN AVG TTM
103.90%
NET PROFIT MARGIN AVG 3Y
10.90%
NET PROFIT MARGIN AVG 5Y
-16.28%
NET PROFIT MARGIN AVG 10Y
-39.14%
NET PROFIT MARGIN AVG 15Y
-88.42%
NET PROFIT MARGIN AVG 20Y
-87.55%
CURRENT VS TTM AVG
+11.93%
CURRENT VS 3Y AVG
+966.55%
CURRENT VS 5Y AVG
+814.31%
CURRENT VS 10Y AVG
+397.16%
CURRENT VS 15Y AVG
+231.54%
CURRENT VS 20Y AVG
+232.84%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+44830.77%
vs the sector median at left
Rigel Pharmaceuticals, Inc.
Market Cap
$856.09M
Net Profit Margin
116.30%
TTM Avg
103.90%
3Y Avg
10.90%
5Y Avg
-16.28%
Market Cap
$856.58M
Net Profit Margin
-6.85%
TTM Avg
-13.95%
3Y Avg
-29.17%
5Y Avg
-39.83%
Market Cap
$867.27M
Net Profit Margin
-39.20%
TTM Avg
-57.59%
3Y Avg
-24.68%
5Y Avg
-1.42%
Market Cap
$863.57M
Net Profit Margin
-173.85%
TTM Avg
-104.63%
3Y Avg
-54.62%
5Y Avg
-54.62%
Market Cap
$847.98M
Net Profit Margin
-5933.45%
TTM Avg
-505.88%
3Y Avg
-252.94%
5Y Avg
-252.94%
Market Cap
$842.69M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$877.05M
Net Profit Margin
-4994.86%
TTM Avg
-4994.86%
3Y Avg
-4994.86%
5Y Avg
-4994.86%
Market Cap
$882.11M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$830.43M
Net Profit Margin
-560.85%
TTM Avg
-63.69%
3Y Avg
-31.84%
5Y Avg
-21.23%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rigel Pharmaceuticals, Inc. (RIGL) | $856.09M | 116.30% | 103.90% | 10.90% | -16.28% |
| SI-BONE, Inc. (SIBN)vs › | $856.58M | -6.85% | -13.95% | -29.17% | -39.83% |
| QuidelOrtho Corporation (QDEL)vs › | $867.27M | -39.20% | -57.59% | -24.68% | -1.42% |
| SL Science Holding Ltd (SLBT)vs › | $863.57M | -173.85% | -104.63% | -54.62% | -54.62% |
| Alumis Inc. (ALMS)vs › | $847.98M | -5933.45% | -505.88% | -252.94% | -252.94% |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $842.69M | 0.00% | 0.00% | 0.00% | 0.00% |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $877.05M | -4994.86% | -4994.86% | -4994.86% | -4994.86% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $882.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $830.43M | -560.85% | -63.69% | -31.84% | -21.23% |
| Pacific Biosciences of California, Inc. (PACB)vs › | $833.97M | -82.49% | -271.33% | -235.13% | -173.69% |
Operating Margin
42.6%
Net Profit Margin
116.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 21.97% |
| 2026-03-31 | 14.71% |
| 2025-12-31 | 384.04% |
| 2025-09-30 | 40.17% |
| 2025-06-30 | 58.63% |
| 2025-03-31 | 21.46% |
| 2024-12-31 | 24.90% |
| 2024-09-30 | 22.46% |
| 2024-06-30 | -2.80% |
| 2024-03-31 | -27.92% |
| 2023-12-31 | 2.06% |
| 2023-09-30 | -20.23% |
| 2023-06-30 | -24.55% |
| 2023-03-31 | -51.92% |
| 2022-12-31 | 2.73% |
| 2022-09-30 | -84.95% |
| 2022-06-30 | -45.25% |
| 2022-03-31 | -164.00% |
| 2021-12-31 | -110.94% |
| 2021-09-30 | -97.26% |
| 2021-06-30 | -52.62% |
| 2021-03-31 | 48.75% |
| 2020-12-31 | -104.27% |
| 2020-09-30 | -77.08% |
| 2020-06-30 | -109.71% |
| 2020-03-31 | 38.10% |
| 2019-12-31 | -111.69% |
| 2019-09-30 | -55.09% |
| 2019-06-30 | -198.00% |
| 2019-03-31 | -139.40% |
| 2018-12-31 | 8.53% |
| 2018-09-30 | -488.51% |
| 2018-06-30 | -1430.16% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | -1962.22% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | -427.29% |
| 2016-12-31 | -519.67% |
| 2016-09-30 | -601.84% |
| 2016-06-30 | -157.47% |
| 2016-03-31 | -347.27% |
| 2015-12-31 | -148.61% |
| 2015-09-30 | -51.34% |
| 2015-06-30 | -268.36% |
| 2015-03-31 | -835.31% |
| 2014-12-31 | -269.96% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | -293.23% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | -1626.29% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | -1649.20% |
| 2012-03-31 | -3089.87% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | -411.73% |
| 2011-06-30 | -5436.46% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 13.79% |
| 2010-09-30 | 69.77% |
| 2010-06-30 | 54.65% |
| 2010-03-31 | -684.85% |
| 2009-12-31 | -3345.73% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | -237.52% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | -983.90% |
| 2007-03-31 | -646.03% |
| 2006-12-31 | -494.12% |
| 2006-09-30 | -185.77% |
| 2006-06-30 | -16.27% |
| 2006-03-31 | -85.57% |
| 2005-12-31 | -147.72% |
| 2005-09-30 | -393.24% |
| 2005-06-30 | -266.89% |
| 2005-03-31 | -426.43% |
| 2004-12-31 | -1338.73% |
| 2004-09-30 | -2448.56% |
| 2004-06-30 | -829.99% |
| 2004-03-31 | -877.67% |
| 2003-12-31 | -563.25% |
| 2003-09-30 | -526.34% |
| 2003-06-30 | -445.55% |
| 2003-03-31 | -173.45% |
| 2002-12-31 | -218.11% |
| 2002-09-30 | -277.63% |
